Importance of shared decision making in the management of endometrial cancer

touchMDT for touchONCOLOGY

Listen to key experts from a multidisciplinary team discuss key considerations in the management of immune-related adverse events with immune checkpoint inhibitors in advanced or recurrent endometrial cancer

The multidisciplinary team:

• Gynaecological oncologist: Prof. Christian Marth, Innsbruck, Austria
• Medical oncologist: Dr Ilaria Colombo, Bellinzona, Switzerland
• Pathologist: Dr Tjalling Bosse, Leiden, Netherlands

This touchPODCAST is for HCPs only.

This activity is funded by an unrestricted independent medical educational grant from GlaxoSmithKline. This activity is provided by touchIME.

For further information visit our website: 
https://touchoncology.com/education/mdt-for-ici-in-ec/